SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2583If you had a 1/2 position in iomi, you now have more than a full position, so I rkrw-5/13/2008
2582Thanks for the update on IOMI, I had not seen it. Yes, I did have some but not Biotech Jim-5/13/2008
2581I just saw the news now(1:30 am est) :-) Iomai at last is getting some profits fdr.praveen-5/13/2008
2580Score 1 for Biotech Jim; congrats if you followed up on your note to buy! rkrw-5/12/2008
2579IOMI Munched for about 150% premium... This explains the really nice positive gapgo-neil-5/12/2008
2578BioMarin Takeover Talk Sparks Surge in Trading By TENNILLE TRACY May 12, 2008; PIan@SI-5/12/2008
2577<i>The market likes the concept, as Opko's AMD drug isn't given muDewDiligence_on_SI-5/8/2008
2576Private munch by Opko, terms not disclosed: >>OPKO Health Acquires Compantuck-5/8/2008
2575BMY to Sell Wound-Care Unit for $4.1B By KATHY SHWIFF May 2, 2008 5:23 p.m. BriIcebrg-5/3/2008
2574For Lipitor King, It’s Deja Vu All Over Again Posted by Ron Winslow May 1, 200Doc Bones-5/2/2008
2573Pfizer is regurgitating Esperion -- for which it paid something like 1.3 billiontuck-5/2/2008
2572Mini munch: 8:52AM Pharmacyclics: RWD Acquisition begins cash tender offer forIan@SI-5/1/2008
25717:05AM Sepracor to acquire Oryx Pharmaceuticals for $50 mln (SEPR) 21.55Ian@SI-5/1/2008
2570SS- There is an interesting/challenging hurdle for these types of trials where Biotech Jim-4/27/2008
2569Interesting discussion. I'll continue this on the Valuation thread to spare Biomaven-4/25/2008
2568I once looked into the mtx dose for PA. My understanding was that liver/white blsoftware salesperson-4/25/2008
2567>> a phase I dose ranging study has failed to identify a maximally toleratscaram(o)uche-4/25/2008
2566Cool, wondered what was driving the sucker. <i>phase II open label extensscaram(o)uche-4/25/2008
2565Rick, <I> (for those who follow this thread but have no biology bkgd., mtsoftware salesperson-4/25/2008
2564Glaxo Says Compound in Wine May Fight Aging <i>I take resveratrol too. Doc Bones-4/25/2008
2563I'd venture Sangamo (SGMO) is a good fit for MRK. They'd probably wait enzyme-4/24/2008
2562Derek Lowe weighs in on the Sitris munch, and provides a little color on sirtuintuck-4/24/2008
2561>> I would want to see longer term data << Me too, except that Iscaram(o)uche-4/23/2008
2560>> 2M shares short! << Cool. Didn't notice that part of your pscaram(o)uche-4/23/2008
2559Nice news. Big pharm has the cash and they are in a sort of a jewelry store. Ikenhott-4/23/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News